
Primary immunodeficiency (PI), including common variable immunodeficiency (CVID), affects the body’s ability to fight infections.
Immunoglobulin therapy, including IVIG and SCIG, is commonly used to help strengthen the immune system and reduce the frequency and severity of infections.
At Mercy Infusion, we provide coordinated immunoglobulin therapy for patients with PI and CVID, with a focus on consistent treatment, insurance support, and ongoing clinical care.
Primary immunodeficiency refers to a group of disorders in which part of the immune system is missing or does not function properly.
CVID is one of the most common forms of primary immunodeficiency.
Patients with PI or CVID may experience:
These conditions are typically managed with ongoing therapy to support immune function.
Immunoglobulin therapy provides the antibodies your body is not producing effectively, helping to strengthen your immune system.
For patients with PI or CVID, IVIG or SCIG therapy may:
For patients living with immune deficiencies, immunoglobulin therapy is delivered with expert care and close monitoring, along with education and support so patients feel confident throughout treatment.
You may be a candidate for immunoglobulin therapy if you:
Our team works closely with your physician to coordinate your care and help ensure consistent access to therapy.
Mercy Infusion offers flexible treatment options depending on your needs and preferences.
IVIG Therapy
SCIG Therapy
Our team helps determine the most appropriate therapy and setting based on your condition, treatment plan, and lifestyle.
At Mercy Infusion, we make ongoing therapy simple and well-coordinated.
Once your physician sends your prescription, our team manages benefits verification, prior authorization, and scheduling so treatment can begin and continue without disruption.
Our goal is to ensure reliable, consistent access to therapy so you can stay on track long term.
Immunoglobulin therapy for primary immunodeficiency is typically covered by insurance when medically necessary.
Mercy Infusion works directly with your insurance provider to:
We also help identify copay assistance and financial support programs that may reduce out-of-pocket costs when eligible.
Patients and providers choose Mercy Infusion because we focus on consistency, coordination, and long-term support.
We help ensure patients with chronic immune conditions can maintain uninterrupted access to therapy.
What is the primary treatment for primary immunodeficiency?
Immunoglobulin therapy, including IVIG and SCIG, is the most common treatment used to support immune function.
What is the difference between IVIG and SCIG?
IVIG is administered through an IV in larger, less frequent doses, while SCIG is given under the skin in smaller, more frequent doses.
How often is treatment needed for CVID?
Treatment is typically ongoing and administered on a regular schedule based on your physician’s recommendations.
Is immunoglobulin therapy covered by insurance?
Most insurance plans cover IVIG and SCIG therapy when medically necessary. Our team handles verification and authorization.
Consistent access to treatment is essential for managing primary immunodeficiency and reducing infections.
Mercy Infusion coordinates every step so you can begin and continue therapy without unnecessary interruptions.